SUD suda pharmaceuticals ltd

Problem, page-11

  1. 455 Posts.
    lightbulb Created with Sketch.  16
    It won't be anywhere near that upfront amount as I'd say they'd be using the new platform, meaning they don't have the data or product patent to justify a $20m upfront.

    I'd guess something around $1m + payments along the way for milestones i.e. once we've got ABC data you get paid xyz. vs a traditional $20m and once you've done the paperwork (registrations + submissions etc.) get another $90m.

    The company has harped on about "Co Dev" deals so I'd say 001 could maybe be that???

    If they use the old platform they might get a larger upfront, but I don't see the company wanting to run with old tech?

    I'd doubt 001 is on the cards though? Wouldn't it be Zolpi or Artimist to land next?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.